These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32871937)

  • 41. No evidence of splenic disease in patients with splenic marginal zone lymphoma undergoing splenectomy for autoimmune hemolytic anemia after monotherapy with rituximab.
    Kalpadakis C; Pangalis GA; Sachanas S; Rontogianni D; Korkolopoulou P; Milionis V; Vassilakopoulos TP; Papadaki HA; Angelopoulou MK
    Leuk Lymphoma; 2016 Nov; 57(11):2705-8. PubMed ID: 27082039
    [No Abstract]   [Full Text] [Related]  

  • 42. Rituximab monotherapy in splenic marginal zone lymphoma: prolonged responses and potential benefit from maintenance.
    Kalpadakis C; Pangalis GA; Sachanas S; Tsirkinidis P; Kontopidou FN; Moschogiannis M; Yiakoumis X; Koulieris E; Dimopoulou MN; Kokkoris SI; Kyrtsonis MC; Siakantaris MP; Tsourouflis G; Korkolopoulou P; Rontogianni D; Tsaftaridis P; Plata E; Papadaki HA; Panagiotidis P; Angelopoulou MK; Vassilakopoulos TP
    Blood; 2018 Aug; 132(6):666-670. PubMed ID: 29914978
    [No Abstract]   [Full Text] [Related]  

  • 43. A Rare Case of Factor VII Inhibitor in a Patient Presenting with Primary Splenic Marginal Zone Lymphoma.
    Naismith K; Allevato PA; Hamm C
    Am J Case Rep; 2021 Sep; 22():e932704. PubMed ID: 34487513
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinicopathological features of splenic tumours of lymphoid tissue.
    Chen DB; Shen DH; Yang SM; Fang XZ
    Pathol Res Pract; 2018 Dec; 214(12):1952-1958. PubMed ID: 30087035
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Splenic marginal zone lymphoma: a case report and literature review.
    Zhang S; Xuan Z; Zhang L; Lu J; Song P; Zheng S
    World J Surg Oncol; 2020 Oct; 18(1):259. PubMed ID: 33004051
    [TBL] [Abstract][Full Text] [Related]  

  • 46. KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotype.
    Clipson A; Wang M; de Leval L; Ashton-Key M; Wotherspoon A; Vassiliou G; Bolli N; Grove C; Moody S; Escudero-Ibarz L; Gundem G; Brugger K; Xue X; Mi E; Bench A; Scott M; Liu H; Follows G; Robles EF; Martinez-Climent JA; Oscier D; Watkins AJ; Du MQ
    Leukemia; 2015 May; 29(5):1177-85. PubMed ID: 25428260
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Clinicopathologic study of splenic marginal zone B-cell lymphoma].
    Zhang YN; Zheng YY; Zhou XG; Zhang SH; Jin Y; Xie JL; Chen SY; Shi Y; Wu LH
    Zhonghua Bing Li Xue Za Zhi; 2009 Apr; 38(4):243-7. PubMed ID: 19575895
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Optimal Rituximab Monotherapy in Splenic Marginal Zone Lymphoma (SMZL): A Case Report and Brief Review.
    Guan RY; Tang XR; Huang ZF; Du J; Fu XH; Lu G; Mou WW
    Recent Pat Anticancer Drug Discov; 2023 Nov; ():. PubMed ID: 37937574
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Improved biological insight and influence on management in indolent lymphoma. Talk 3: update on nodal and splenic marginal zone lymphoma.
    Thieblemont C
    Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):371-378. PubMed ID: 29222281
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Still a role for surgery as first-line therapy of splenic marginal zone lymphoma? Results of a prospective observational study.
    Pata G; Bartoli M; Damiani E; Solari S; Anastasia A; Pagani C; Tucci A
    Int J Surg; 2017 May; 41():143-149. PubMed ID: 28366762
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Blastic transformation after splenectomy in a patient with nonvillous splenic marginal zone lymphoma with p53 overexpression: a case report.
    Kakinoki Y; Kubota H; Sakurai H; Sato T; Tokusashi Y
    Int J Hematol; 2005 Jun; 81(5):417-20. PubMed ID: 16158823
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rituximab, used alone or in combination, is superior to other treatment modalities in splenic marginal zone lymphoma.
    Else M; Marín-Niebla A; de la Cruz F; Batty P; Ríos E; Dearden CE; Catovsky D; Matutes E
    Br J Haematol; 2012 Nov; 159(3):322-8. PubMed ID: 23016878
    [TBL] [Abstract][Full Text] [Related]  

  • 53. First-line treatment with bendamustine and rituximab, in patients with intermediate-/high-risk splenic marginal zone lymphomas.
    Castelli R; Bergamaschini L; Deliliers GL
    Med Oncol; 2017 Dec; 35(2):15. PubMed ID: 29288421
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hepatitis C virus infection and locally advanced splenic marginal zone lymphoma.
    Szynglarewicz B; Matkowski R; Smorag Z; Forgacz J; Pudelko M; Kornafel J
    Pathol Oncol Res; 2007; 13(4):382-4. PubMed ID: 18158578
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Laparoscopic splenectomy for treatment of splenic marginal zone lymphoma.
    Wu Z; Zhou J; Wang X; Li YB; Niu T; Peng B
    World J Gastroenterol; 2013 Jun; 19(24):3854-60. PubMed ID: 23840125
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Splenic marginal zone lymphoma: disease features and management.
    Matutes E
    Expert Rev Hematol; 2013 Dec; 6(6):735-45. PubMed ID: 24168526
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Successful rechallenge of rituximab following severe rituximab-induced acute thrombocytopenia in a patient with splenic marginal zone lymphoma.
    Robinson AC; Nachar VR
    J Oncol Pharm Pract; 2020 Jul; 26(5):1248-1253. PubMed ID: 31766968
    [TBL] [Abstract][Full Text] [Related]  

  • 58. NOTCH signaling in the pathogenesis of splenic marginal zone lymphoma-opportunities for therapy.
    Alderuccio JP; Lossos IS
    Leuk Lymphoma; 2022 Feb; 63(2):279-290. PubMed ID: 34586000
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rituximab monotherapy is highly effective in splenic marginal zone lymphoma.
    Kalpadakis C; Pangalis GA; Dimopoulou MN; Vassilakopoulos TP; Kyrtsonis MC; Korkolopoulou P; Kontopidou FN; Siakantaris MP; Dimitriadou EM; Kokoris SI; Tsaftaridis P; Plata E; Angelopoulou MK
    Hematol Oncol; 2007 Sep; 25(3):127-31. PubMed ID: 17514771
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rituximab Monotherapy or in Combination with Bendamustine Is Not Inferior to Rituximab-CHOP Regimen in the Treatment of Patients with Splenic Marginal Zone Lymphoma in the Real Life.
    Mulas O; Caocci G; Dessì D; Mantovani D; Moi G; Cabras MG; La Nasa G
    Acta Haematol; 2021; 144(3):322-326. PubMed ID: 32892194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.